The substantial reduction in price target by a major analyst like Morgan Stanley is likely to negatively impact investor sentiment and the stock price of Outset Medical in the short term. The Equal-Weight rating suggests that the analyst sees the stock as fairly valued at its current price, but the lowered price target indicates a significant revision of the stock's valuation, which could lead to a decrease in stock price as the market adjusts to the new valuation.